» Articles » PMID: 37378077

The Role of Vitamin D in Menopausal Women's Health

Overview
Journal Front Physiol
Date 2023 Jun 28
PMID 37378077
Authors
Affiliations
Soon will be listed here.
Abstract

Vitamin D (VD) is known to play an important role in the maintenance of calcium homeostasis and bone metabolism. In recent years, there has also been a growing interest in Vitamin D for health issues beyond the bones. Menopausal women are at risk of reduced bone density and increased risk of fracture due to a decline in estrogen levels. There is also an increased risk of cardiovascular disease, diabetes and hyperlipidaemia due to impaired lipid metabolism. The menopausal and emotional symptoms due to menopause are also increasingly prominent. This article summarizes the role of Vitamin D in menopausal women's health, including the effects of Vitamin D on skeletal muscle, cardiovascular disease, Genitourinary Syndrome of Menopause (GSM), cancer and emotional symptoms. Vitamin D regulates the growth of vaginal epithelial cells and alleviates genitourinary tract problems in menopausal women. Vitamin D also modulates immune function and influences the production of adipokines. Vitamin D and its metabolites also have an anti-proliferative effect on tumour cells. This narrative review, by summarizing recent work on the role of Vitamin D in menopausal women and in animal models of menopause, aims to provide a basis for further development of the role of Vitamin D in the health of menopausal women.

Citing Articles

Artificial intelligence-based cardiovascular/stroke risk stratification in women affected by autoimmune disorders: a narrative survey.

Tiwari E, Shrimankar D, Maindarkar M, Bhagawati M, Kaur J, Singh I Rheumatol Int. 2025; 45(1):14.

PMID: 39745536 DOI: 10.1007/s00296-024-05756-5.


Effect of Vitamin D Level on Female Vaginitis in Xi'an, China.

Guan J, Dong Y, Zhang W, Gui Q, Luo D, Wen H Int J Womens Health. 2024; 16:2103-2112.

PMID: 39659295 PMC: 11630696. DOI: 10.2147/IJWH.S481539.


Clinical efficacy of gamma-oryzanol combined with Femoston for perimenopausal syndrome.

Kuang Y, Xiong M, Cai J World J Clin Cases. 2024; 12(22):4992-4998.

PMID: 39109013 PMC: 11238790. DOI: 10.12998/wjcc.v12.i22.4992.


Investigating the Effects and Mechanisms of Combined Vitamin D and K Supplementation in Postmenopausal Women: An Up-to-Date Comprehensive Review of Clinical Studies.

Rusu M, Bigman G, Ryan A, Popa D Nutrients. 2024; 16(14.

PMID: 39064799 PMC: 11279569. DOI: 10.3390/nu16142356.


[Resolution of the national interdisciplinary council of experts "High-dose vitamin D (Devilam) in the practice of an obstetrician-gynecologist"].

Andreeva E, Artymuk N, Vesnina A, Zazerskaya I, Karakhalis L, Katkova N Probl Endokrinol (Mosk). 2024; 70(2):103-116.

PMID: 38796767 PMC: 11145572. DOI: 10.14341/probl13465.


References
1.
Vacek J, Vanga S, Good M, Lai S, Lakkireddy D, Howard P . Vitamin D deficiency and supplementation and relation to cardiovascular health. Am J Cardiol. 2011; 109(3):359-63. DOI: 10.1016/j.amjcard.2011.09.020. View

2.
Rammos G, Tseke P, Ziakka S . Vitamin D, the renin-angiotensin system, and insulin resistance. Int Urol Nephrol. 2008; 40(2):419-26. DOI: 10.1007/s11255-007-9244-4. View

3.
Mohanty S, Kamolvit W, Hertting O, Brauner A . Vitamin D strengthens the bladder epithelial barrier by inducing tight junction proteins during E. coli urinary tract infection. Cell Tissue Res. 2020; 380(3):669-673. PMC: 7242269. DOI: 10.1007/s00441-019-03162-z. View

4.
Karthikayan A, Sureshkumar S, Kadambari D, Vijayakumar C . Low serum 25-hydroxy vitamin D levels are associated with aggressive breast cancer variants and poor prognostic factors in patients with breast carcinoma. Arch Endocrinol Metab. 2018; 62(4):452-459. PMC: 10118730. DOI: 10.20945/2359-3997000000062. View

5.
Indhavivadhana S, Boonyachan W, Rattanachaiyanont M, Wongwananuruk T, Techatraisak K, Sa-Nga-Areekul N . Effectiveness of vitamin D2 supplementation on high-sensitivity C-reactive protein and other metabolic indices in menopausal Thai women: a randomized-controlled trial. Gynecol Endocrinol. 2021; 38(1):83-89. DOI: 10.1080/09513590.2021.1988560. View